The role of oral 1C antiarrhythmic drugs in terminating atrial fibrillation

Current Opinion in Cardiology

Volumn 14, Issue 1, 1999, Pages 4-8

  Capucci, Alessandro ^a   Villani, Giovanni Quinto ^a   Piepoli, Massimo F ^a   Aschieri, Daniela ^a  

^a Ospedale Civile di Piacenza   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; FLECAINIDE; PROPAFENONE;

DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE ARRHYTHMIA; HUMAN; OUTPATIENT CARE; PRIORITY JOURNAL; SHORT SURVEY; SUPRAVENTRICULAR TACHYCARDIA;

ADMINISTRATION, ORAL; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ATRIAL FIBRILLATION; FLECAINIDE; HUMANS; PROPAFENONE;

EID: 0033025429     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199901000-00002     Document Type: Short Survey

References (19)

1. 1 Peters KG, Kienzle MG. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm. Am J Med 1988, 85:242-244.
2. 2 Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992, 69:1570-1573.
3. 3 Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. Circulation 1995, 92:1-15.
4. 4 Allessie M, Kirchhof C, Sceffer GJ, Chorro F, Brugada J. Regional control of atrial fibrillation by rapid pacing in conscious dogs. Circulation 1991, 84:1689-1697.
5. 5 Capucci A, Biffi M, Boriani G, Ravelli F, Nollo G, Sabbatani P, Orsi C, Magnani B. Dynamic electrophysiologic behavior of human atria during paroxysmal atrial fibrillation. Circulation 1995, 92:1193-1202.
6. 6 Matsuo K, Kumagai K, Annoura M, Ideishi M, Arakawa K. Mechanism of antiarrhythmic effects of class 1c drugs in paroxysmal atrial fibrillation in man. Cardiology 1998, 89:119-123. Electrophysiologic evaluation of the mechanism of action of class 1C drugs, which seem to reduce atrial vulnerability by increasing the wavelength of the reentrant circuit during periods of rapid heart rate.
7. 7 Naccarelli GV, Dorian P, Hohnloser SH, Coumel P. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group. Am J Cardiol 1996, 77:53A-59A.
8. 8 Villani GQ, Rosi A, Piepoli M, Gandolfini A, Groppi F, Groppi M, Arruzzoli S, Dieci G, Gazzola U. The efficacy of oral treatment with flecainide for paroxysmal atrial fibrillation: correlation with plasma concentration. G Ital Cardiol 1990, 20:564-568.
9. 9 Capucci A, Lenzi T, Boriani G, Trisolino G, Binetti N, Cavazza M, Fontana G, Magnani B. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 1992, 70:69-72.
10. 10 Capucci A, Boriani G, Botto GL, Lenzi T, Falcone C, Trisolino G, Dallacasa S, Binetti N, Cavazza M. Conversion of recent onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol 1994, 74:503-505.
11. 11 Botto GL, Bonini W, Broffoni T, Cappelletti G, Falcone C, Lombardi R, Paulesu Pedraglio E, Ferrari G. Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm. PACE Pacing Clin Electrophysiol 1994, 17:2114-2117.
12. 12 Crijns HJ, van Wijk LM, van Gilst WH, Kingma JH, van Gelder IC, Lie Kl. Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens. Eur Heart J 1988, 9:634-638.
13. 13 Capucci A, Boriani G, Rubino I. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol 1994, 43:305-331.
14. 14 Weiner P, Ganam R, Ganem R, Zidan F, Rabner M. Clinical course of recent onset atrial fibrillation. Chest 1994, 105:1013-1016.
15. 15 Boriani G, Capucci A, Lenzi T. Propafenone for conversion of a recent onset atrial fibrillation. Chest 1995, 108:355-358.
16. 16 Botto GL, Capucci A, Bonini W, Boriani G, Broffoni T, Barone P, Espureo M, Lombardi R, Molteni S, Ferrari G. Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. Int J Cardiol 1997, 58:55-61. An acute oral administration of 450 or 600 mg of propafenone has been shown to be more effective than placebo in rapidly converting recent-onset AF without side effects.
17. 17 Boriani G, Biffi M, Capucci A, Botto GL, Broffoni T, Rubino I, Dalla Casa S, Sanguinetti M, Magnani B. Oral propafenone to convert recent onset atrial fibrillation in patients with and without underlying heart disease. Ann Intern Med 1997, 126:621-625. The propafenone was more effective than placebo in the conversion to sinus rhythm of AF also in patients with structural heart disease.
18. 18 Azpitarte J, Alvarez M, Baun O, Garcia R, Moreno E, Martin F, Tercedor L, Fernanez R. Value of single oral loading dose of propafenone in converting recent onset atrial fibrillation. Results of a randomized double blind controlled study. Eur Heart J 1997, 18:1649-1654. The efficacy and the rapid action of oral propafenone terminating AF are confirmed.
19. 19 Capucci A, Aschieri D, Villani GQ. Clinical pharmacology of antiarrhythmic drugs. Drugs Aging 1998, 13:51-70.